Correlation Between Emergent Biosolutions and RAMM Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and RAMM Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and RAMM Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emergent Biosolutions and RAMM Pharma Corp, you can compare the effects of market volatilities on Emergent Biosolutions and RAMM Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of RAMM Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and RAMM Pharma.

Diversification Opportunities for Emergent Biosolutions and RAMM Pharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Emergent and RAMM is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and RAMM Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RAMM Pharma Corp and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with RAMM Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RAMM Pharma Corp has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and RAMM Pharma go up and down completely randomly.

Pair Corralation between Emergent Biosolutions and RAMM Pharma

If you would invest  929.00  in Emergent Biosolutions on October 4, 2024 and sell it today you would earn a total of  27.00  from holding Emergent Biosolutions or generate 2.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy4.55%
ValuesDaily Returns

Emergent Biosolutions  vs.  RAMM Pharma Corp

 Performance 
       Timeline  
Emergent Biosolutions 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Emergent Biosolutions are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental drivers, Emergent Biosolutions may actually be approaching a critical reversion point that can send shares even higher in February 2025.
RAMM Pharma Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days RAMM Pharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable primary indicators, RAMM Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Emergent Biosolutions and RAMM Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Emergent Biosolutions and RAMM Pharma

The main advantage of trading using opposite Emergent Biosolutions and RAMM Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, RAMM Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RAMM Pharma will offset losses from the drop in RAMM Pharma's long position.
The idea behind Emergent Biosolutions and RAMM Pharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets